Figure 3.
Kaplan-Meier curves for patient survival. Patients with a high Cav-1 metastatic tumor showed a significantly shorter relapse-free survival (a) and cancer-specific survival (b) after surgery than those with a low Cav-1 tumor (P = 0.002 and P = 0.004, resp.). In patients with lymph node metastasis, high metastatic tumoral Cav-1 expression was associated with shorter relapse-free survival (c) and cancer-specific survival times (d) (P = 0.002 and P = 0.005, resp.).